Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.nature.com/articles/s41574-020-0341-0.pdf
Reference172 articles.
1. Caplan, A., Fett, N., Rosenbach, M., Werth, V. P. & Micheletti, R. G. Prevention and management of glucocorticoid-induced side effects: a comprehensive review: a review of glucocorticoid pharmacology and bone health. J. Am. Acad. Dermatol. 76, 1–9 (2017).
2. Kaltsas, G. & Makras, P. Skeletal diseases in Cushing’s syndrome: osteoporosis versus arthropathy. Neuroendocrinology 92 (Suppl. 1), 60–64 (2010).
3. Devogelaer, J. P., Crabbe, J. & Nagant de Deuxchaisnes, C. Bone mineral density in Addison’s disease: evidence for an effect of adrenal androgens on bone mass. Br. Med. J. 294, 798–800 (1987).
4. Bjornsdottir, S. et al. Risk of hip fracture in Addison’s disease: a population-based cohort study. J. Intern. Med. 270, 187–195 (2011).
5. Vandewalle, J., Luypaert, A., De Bosscher, K. & Libert, C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol. Metab. 29, 42–54 (2018).
Cited by 223 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Glucocorticoid-induced osteoporosis is prevented by dietary prune in female mice;Frontiers in Cell and Developmental Biology;2024-02-05
2. Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis;BMC Musculoskeletal Disorders;2024-02-03
3. Reply: Unraveling the Hypocalcemic Response to177Lu-Prostate-Specific Membrane Antigen Therapy;Journal of Nuclear Medicine;2024-02
4. Safety of non-standard regimen of systemic steroid therapy in patients with Graves’ orbitopathy: a single-centre experience;Pharmacological Reports;2024-01-26
5. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan;Osteoporosis International;2024-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3